IL2 and colorectal carcinoma: CTLs in the TME of CRC produce high amounts of IL-2, IL-12 and IFN-γ that activate the killing efficiency of NK cells and CTLs [202] and enhance the expression of CXCL-9, CXCL-10 and CXCL-11 in epithelial cancer cells [203].